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Background: Combination therapies used to treat the photoaged skin have become more popular as studies
demonstrate greater efﬁcacy and improved clinical outcomes compared to single treatment modalities.
Objectives: To evaluate the safety and effectiveness of treating the lateral canthal rhytide complex with a
Jessner’s and 35% TCA peel with and without pretreatment with BTX-A.
Methods: Twenty-six subjects with Fitzpatrick skin types I -III were randomized to receive treatment of their
lateral canthal rhytide complex with a Jessner’s and 35% TCA peel with or without pretreatment with BTX-A. A
single blinded dermatologist assigned a lateral canthal wrinkle score of subjects’ at baseline and week 8-10.
Results: Comparison between the two treatment groups demonstrated that the group receiving combination
treatment had signiﬁcantly greater improvement in wrinkle reduction as compared to the group only
receiving the chemical peel (P =0.002). In addition, there was no signiﬁcant association between skin type
and treatment groups (P = 0.11).
Conclusions: These ﬁndings suggest that treating the lateral canthal rhytide complex with a combination of
BTX-A followed by Jessner’s and 35% TCA peel is more effective than chemical peel alone. These results are
independent of skin type and demonstrate an additional treatment strategy for lateral canthal rhytides.
© 2016 The Authors. Published by Elsevier Inc. on behalf of Women's Dermatologic Society. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Lateral canthal rhytides, commonly referred to as crow’s feet, are
wrinkles of the lateral periorbital skin that are caused by contraction of
the orbicularis oculi muscles (Lowe et al., 2005); they commonly affect
women and contribute to an aged appearance. Repetitive movement
over time induces atrophy of overlying skin and subcutaneous tissue
compounded by pigmentary and textural changes brought on by chronic
photodamage. To improve the appearance of this region, a variety of
procedures from the cosmetic armamentariummay be employed singly
ormore frequently in combination: chemical peels, injectable botulinum
toxins and dermalﬁllers, nonablative and ablative laser treatments, and a
diverse array of topical agents (Tierney and Hanke, 2010).
Onabotulinum toxin type A (onaBTX-A) is extensively used in clinical
practice to treat the hyperdynamic facialmuscles that can create rhytides
(Lowe et al., 2005). Injection into the muscles causes a reversible
immobilization of muscle contraction by inhibiting acetylcholine release).
ofWomen'sDermatologicSociety.Thisisanfrom the cholinergic nerve terminal innervating the muscle (Lowe et al.,
2005). OnaBTX-A not only relaxes the overactive muscles that produce
dynamic wrinkles, but it can also be used as an adjunctive procedure to
supplement resurfacing procedures like chemical peeling (Tung et al.,
2011). By reducing activity of speciﬁc muscle groups with onaBTX-A
before peeling, the overlying skin is less subject to the deleterious effects
of repetitive movement (Tung et al., 2011). In this reduced kinetic state,
healing can progress relatively undisturbed, and new collagen produc-
tion will be more uniform (Tung et al., 2011).
Chemical peels are used for a variety of therapeutic indications,
including facial rhytides, pigmentary changes, textural irregularities,
and precancerous skin lesions (Monheit, 2001; Tung et al., 2011). They
produce controlled exfoliation and damage of the epidermis and
variably affect the dermis, depending on the peel type (Tung et al.,
2011). Medium depth peels such as trichloroacetic acid (TCA) initially
cause necrosis of the epidermis as well as all or part of the papillary
dermis with attendant inﬂammation of the reticular dermis (Monheit,
2001; Tung et al., 2011). During the regeneration phase, the treated skin
is shed followed by re-epithelialization and stimulation of collagen
synthesis in the dermis (Monheit, 2001; Tung et al., 2011). The
combination of Jessner’s superﬁcial peelwith 35% TCAmedium strength
peel is designed to produce rejuvenation in a well-tolerated andopenaccessarticleundertheCCBY-NC-NDlicense(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Grade 0 = no wrinkles 
Grade 1 = mild wrinkles 
Grade 2 = moderate wrinkles 
Grade 3 = severe wrinkles 
Fig. 1. Facial Wrinkle Severity Scale (FWSS). Grade 0 = no wrinkles. Grade 1 = mild
wrinkles. Grade 2 = moderate wrinkles. Grade 3 = severe wrinkles.
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improvement of skin qualities including sallowness, atrophy, and ﬁne
rhytides can be expected (Tung et al., 2011). This combination peel is
frequently used to treat mild to moderate photoaging in skin types I–III
due to its predictable clinical beneﬁts andminimal risk of complications
(Landau, 2006; Tung et al., 2011).
Combination therapies used to rejuvenate photoaged skin have
become more popular as there is growing evidence to support greater
efﬁcacy and improved clinical outcomes compared with single
treatment modalities. Our study compares the safety and efﬁcacy of
medium depth chemical resurfacing (Jessner’s and 35% TCA peel)with
and without adjunctive administration of onaBTX-A in the treatment
of mild to moderate rhytides in the lateral canthal region.
Methods
Study design
This study was a rater blinded, randomized controlled trial. After
attaining approval for this study by the Loyola University Health
System Institutional Review Board, patients were recruited via the
clinicaltrials.gov website and from the outpatient dermatology clinic
in La Grange, Ilinois.
Subject selection
Twenty-six subjects were enrolled in this study. Included subjects
could be 30 to 75 years oldwith a skin type from I to III in good general
health and with a mild to moderate lateral canthal rhytide complex of
at least 1 on the four-point facial wrinkle severity scale (FWSS)
(Fig. 1). Exclusion criteria included pregnancy and lactation, prior
treatment in the periorbital region with botulinum toxin injections
within the previous six months, ablative laser resurfacing (previous
six months), nonablative skin tightening procedure (previous six
months), medium-to-deep chemical peels or dermabrasion (previous
six months), temporary hyaluronic acid soft-tissue augmentationFig. 2. The designated areas indicate where to start and stop peeling in the periocular region.material (prior year), semi-permanent (poly-L-lactate or calcium
hydroxylapatite) soft tissue augmentation material (prior two years),
any permanent soft tissue augmentation material, and any surgical
lifting procedure. Also excluded were persons planning to receive any
of the above cosmetic procedures within the subsequent six months
and individuals with active infections of the face; allergies to albumin,
Aquaphor (Beirsdorf, Hamburg, Germany), or petrolatum ointment; a
history of neuromuscular disorders; or a bleeding diathesis.
Study procedures
At the screening and initial treatment visit, subjects’ medical
history and Fitzpatrick skin type were recorded. Baseline photographs
were also obtained, and a blinded physician assigned a lateral canthal
wrinkle score using the four-point FWSS (Fig. 1). Subjects were then
randomized by a computer program to one of two groups: group A
received pretreatment with onaBTX-A before application of the
combined chemical peel of Jessner’s solution to the entire face
followed by 35% TCA only to the upper and lower eyelids (Fig. 2);
group B received treatment with the chemical peels alone. Patients
randomly assigned to group A received onaBTX-A injections to their
lateral canthal wrinkles at the baseline visit. One week after onaBTX-A
injections, group A patients returned to clinic to receive application of
the chemical peels. Those randomly assigned to group B received
application of the chemical peels one week after their baseline visit.
Wound care instructions were reviewed with subjects both before
and after their chemical peels. The same dermatologist performed all
procedures to avoid inter-physician variability in technique.
At weeks 1, 4, and 10 after application of chemical peels, subjects
were seen in follow-up for photography. Blinded FWSS ratings were
made at week 10 based on evaluation of photographs. At each visit,
adverse events and any changes tomedicationswere recorded. Over the
counter topical steroids preparations (hydrocortisone 1% ointment)
were recommended for “spot” treatment in any subjects with excess
focal erythema. All data was collected at Loyola University Health
System, in the division of Dermatology.
OnaBTX-A injection technique
Areas to be treated were cleansed with 70% alcohol; 7.5 units of
onaBTX-A (reconstituted with bacteriostatic-preserved saline resulting
in a concentration of 5 units/0.1mL)was injected into the lateral canthal
rhytides via 3 to 4 injection points, 1 cm lateral from the orbital rim on
each side, resulting in 15 total units of onaBTX-A. A 0.5 inch 32-gauge
needlewasused.OnaBTX-Awasgiven7daysbefore the chemical peel in
patients randomly assigned to Group A only.
Chemical peel technique
After thorough cleansing of the entire facewith amild cleanser and
water followed by gentle removal of surface oil with alcohol wipes,
two coats of the Jessner’s peel solution were applied to the entire face
and left in place for threeminutes until mild erythemawith ﬁnewhite
speckling appeared. Afterward, three to four coats of the 35% TCA peel
solution were applied to the upper lid from the inferior edge of the
brow to the entire lid surface up to the supratarsal crease (Fig. 2). On
the lower lid, two coats of the 35% TCA peel were applied from the
orbital rim to within 3 mm of the lower lash line (Fig. 2). The 35% TCA
peel was left in place until a white frost with background erythema
appeared (a Level 2 frost according to the frosting grading system)
[Appendix I]. Next, cool water compresses were placed on the face for
ﬁve minutes. A light application of triamcinolone acetonide 0.1%
ointment was then applied to the entire face. On the morning
following the peel, subjects were advised to cleanse with a mild,
Table 1







Mean age 51.86 47.27 .13
Pretreatment scores 2.71 2.45 .16
Post-treatment scores 1.79 0.55 .002
Difference pretreatment vs. posttreatment 0.93 1.91 .001
BTX-A, botulinum toxin type A.
Mean values presented.
⁎ p value using Wilcoxon tests.
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or Aquaphor ointment four to ﬁve times per day for the ﬁrst two days
and then three times daily until re-epithelialized.Fig. 4. Subject treated with combination (onaBTX-A + chemical peel) at baseline (left)
and at 10 weeks (right).Primary outcome measures
Our primary objective was to evaluate the safety and efﬁcacy of
sequential use of onaBTX-A with Jessner’s and TCA peels for the
treatment of mild to moderate periocular rhytides. We also compared
the relative effectiveness of using chemical peels alone versus
chemical peels with adjunctive onaBTX-A. Lateral canthal wrinkle
scores using the four-point FWSS were assessed at baseline and week
10 (Fig. 1).Statistical analysis
Data was analyzed with the Wilcoxon signed-rank test for paired
comparisons. Blinded rater scores and age were compared between
treatments (onaBTX-A plus peel vs. peel alone). In addition, Fisher’s
exact test was used to examine the association between skin type
and treatments.Fig. 3. Subject treated with combination (onaBTX-A + chemical peel) at baseline (left)
and at 10 weeks (right).Results
Twenty-six subjectswere consented and enrolled, and 25 completed
the study. Themeanage of the subjectswas 48years old (range: 39–65).
Mean blinded ratings are displayed in Table 1.
Whenassessedatweek10, themeanFWSSscores in subjects receiving
combination treatment (i.e., onaBTX-A + chemical peels – Group A post
score = 0.55) were signiﬁcantly (p = .002) lower than FWSS scores in
patients treatedwith peels only (post score=1.79). Although all subjects
in the combination arm demonstrated improvement from baseline, only
12 out of 14 treated with chemical peel alone (i.e., Group B) showed
improvement in lateral canthal rhytides. Compared with baseline, FWSS
scores were decreased by a signiﬁcantly (p = .001) greater amount on
average at week 10 with combination treatment (onaBTX-Aand peels
score difference = 1.91) compared with peels alone (peels only score
difference = 0.93). There was a signiﬁcantly greater improvement in
lateral canthal rhytides in those receiving combination treatments
compared with those who received chemical peel alone (p = .002)
(Figs. 3 and 4). There was no signiﬁcant difference in pretreatment
wrinkle scores or patient age between groups (p = .16, p = .13,
respectively; Table 1). In addition, there was no signiﬁcant association in
skin type between groups (p= .11, Fisher’s exact test).
All but one subject completed the study. The subject whowithdrew
only received the initial onaBTX-A treatmentwithout complication; she
stated that she couldnot continue toparticipate in the studydue towork
schedule limitations.No serious adverse eventswere reported. Only two
subjects experienced mild irritant dermatitis from the chemical peel
within ﬁve days of the procedure, which fully resolved with application
of topical steroids of lower strength (desonide 0.05% ointment applied
twice a day for three days). Both of these subjects had skin type I and
were from Group A.
Discussion
The results of this study found that treating lateral canthal rhytide
complex with a combination of onaBTX-A injections followed by
Jessner’s and 35% TCA peel is more effective than treatment with the
34 R. Tung et al. / International Journal of Women's Dermatology 2 (2016) 31–34chemical peel alone. In addition, this combination procedure regimen
is well tolerated. We did not ﬁnd any correlation between treatment
efﬁcacy and skin type. With respect to mild adverse events, both
subjects who experienced mild irritant dermatitis had type I skin.
The use of a combined approach in the treatment of photoaged skin
hasbecomemorepopular over theyears. In the literature, studies andcase
reports have highlighted the success of multimodal regiments (involving
adjunctive neuromodulator with ﬁllers, intense pulse light, and laser
resurfacing) within the aesthetic realm for improvement of rhytides
and photodamage (Carruthers and Carruthers, 2003; Carruthers and
Carruthers, 2004; Dubina et al., 2013; Goldman and Wollina, 2010;
Kadunc et al., 2007; Khoury et al., 2008; Tierney and Hanke, 2010).
Botulinum toxin has also proven helpful within the surgical sphere to
minimizepostoperative scar formation (Flynn, 2009;Gassner et al., 2006).
OnaBTX-A is commonly used in combination treatment regimens
due to its beneﬁcial effect on wound healing (Gassner et al., 2006).
When facial muscles are weakened by onaBTX-A, the overlying
immobilized skin can regenerate more efﬁciently and collagen
remodeling is more uniform (Tung et al., 2011). OnaBTX-A is known
to have a rapid onset of activity with peak beneﬁts usually occurring
approximately one-week posttreatment (Carruthers and Carruthers,
1998; Lowe et al., 2005). For this reason, many practitioners advocate
pretreatment with neuromodulators before other aesthetic procedures
to attainmaximal synergy (Carruthers and Carruthers, 1998; Carruthers
and Carruthers, 2003; Carruthers and Carruthers, 2004; Dubina et al.,
2013; Kadunc et al., 2007; Khoury et al., 2008; Landau, 2006; Tung et al.,
2011). In a randomized, blinded, split-face study, Khoury et al. (2008)
found that a signiﬁcantly higher proportion of patients showed
improvement in small wrinkles and ﬁne lines with intense pulse laser
plus BTX-A versus intense pulse laser alone (Khoury et al., 2008). In
addition, a small pilot randomized controlled trial examined the effects
of BTX-A pretreatment with chemabrasion (35% TCA peel with manual
dermabrasion) (Kadunc et al., 2007). Kadunc et al. (2007) found that the
use of adjunctive pretreatment of BTX-A improved both short- and
long-term results of perioral rhytide chemabrasion.
Beneﬁcial effects of onaBTX-A treatment onwound healing have also
been shown to reduce scarring after traumatic forehead laceration repair
and Mohs surgery (Flynn, 2009; Gassner et al., 2006). A prospective,
blinded, placebo-controlled study demonstrated that BTX-A induced
immobilization of forehead wounds enhanced wound healing and
improved cosmesis (Gassner et al., 2006). In addition, a retrospective
analysis found that administration of intraoperative BTX-A treatment in
patients undergoing surgical reconstruction following Mohs procedure
and reconstruction improved wound healing by reducing skin tension
and facilitating the apposition of wound edges (Flynn, 2009).
This study is limitedbecausenogroupreceivedBTX-Aalone.Our study
highlights the tolerability and efﬁcacy of combination treatment usingonaBTX-A and chemical peels for improvement of the lateral canthal
rhytide complex in skin types I through III. However, itwouldbebeneﬁcial
for future studies to evaluate the role of BTX-A alone versus combination
therapies. Overall, althoughmany resurfacing methods exist, a neuromo-
dulator and medium depth chemical peel pairing offers reliable,
cost-effective rejuvenation for mild to moderate periocular rhytides.Appendix I. Frosting Grading System (FGS)
Level of Frost I = speckled white, mild erythema
Level of Frost II = Even white coat, background erythema
Level of Frost III = Solid white, opaque, no background erythema,
penetration into reticular dermis.References
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